Novo Nordisk FDA Warning — Semaglutide PADE Compliance Failure 2026
Canonical vault note: Ozempic FDA Warning Letter 2026.
This legacy regulatory note was superseded during Batch 181 so the graph has one retrieval hub for FDA Warning Letter MARCS-CMS 717576. Keep this stub only to preserve older wikilinks.